Novo Nordisk
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, and the world leader in diabetes care. The company also develops treatments for obesity, rare blood disorders, and growth-hormone therapy, including its widely known GLP-1 medicines Ozempic, Wegovy, and Rybelsus. Novo Nordisk does not publish a public commercial developer API. The company maintains a research GitHub organization (novonordisk-research) that releases open-source scientific computing libraries and an SDK for the Waters Empower Web API (OptiHPLCHandler) used in pharmaceutical analytical chemistry workflows.
Novo Nordisk is profiled on the APIs.io network. Tagged areas include Pharmaceutical, Healthcare, Biotechnology, Diabetes, and Obesity.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API